Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2019
2019 World Conference on Lung Cancer
Access to all presentations that occur during the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2848
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
P2.11 - Screening and Early Detection
- Type: Poster Viewing in the Exhibit Hall
- Track: Screening and Early Detection
- Presentations: 15
- Now Available
- Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
-
+
P2.11-01 - Novel Flexible Longitudinal Machine Learning Coupled with Patient Demographics Improves Lung Cancer Risk Prediction Using Whole Screening CTs
10:15 - 10:15 | Presenter: Kim Lori Sandler
- Abstract
Loading... -
+
P2.11-02 - Individualized Risk-Based Lung Cancer Screening Incorporating Past Screening Findings and Changes in Smoking Behaviors
10:15 - 10:15 | Presenter: Iakovos Toumazis
- Abstract
Loading... -
+
P2.11-03 - Implementing Physician Education to Increase Lung Cancer Screening Compliance (Now Available)
10:15 - 10:15 | Presenter: Coral Olazagasti
- Abstract
Loading... -
+
P2.11-04 - Longitudinal Surveillance of Circulating Tumor Cell in Patients Who Presented with Resectable Pulmonary Lesion Suspicious Malignancy
10:15 - 10:15 | Presenter: Ching Yang Wu
- Abstract
Loading... -
+
P2.11-05 - Peripheral Blood-Based T Cell Receptor Signatures as Potential Biomarkers for Early Diagnosis of Lung Cancer
10:15 - 10:15 | Presenter: Min Li
- Abstract
Loading... -
+
P2.11-06 - Serum Proteomic Signature as a Potential Biomarker for Survival in Patients with NSCLC Receiving Immunotherapy (Now Available)
10:15 - 10:15 | Presenter: Won Bin Kim
- Abstract
Loading... -
+
P2.11-07 - Benefits and Harms of Contemporary Lung Cancer Screening: An Infographic to Support Public and Patient Education
10:15 - 10:15 | Presenter: Hilary Robbins
- Abstract
Loading... -
+
P2.11-08 - CT Screening of Never Smokers
10:15 - 10:15 | Presenter: Claudia I Henschke
- Abstract
Loading... -
+
P2.11-09 - Australia-Wide Cross-Sectional Survey of General Practitioners’ Knowledge and Practice of Lung Cancer Screening (Now Available)
10:15 - 10:15 | Presenter: Prarthana Abeyweera
- Abstract
Loading... -
+
P2.11-10 - Discovery of Potential Biomarkers That Discriminate Early Stage NSCLC from Controls by Non-Targeted Metabolomics Profiling
10:15 - 10:15 | Presenter: Julian Oliver Kim
- Abstract
Loading... -
+
P2.11-11 - Exosomal miRNAs as Diagnosis Biomarkers for Distinguishing Benign and Malignant Nodules in Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Di Zheng
- Abstract
Loading... -
+
P2.11-12 - Sputum Liquid Biopsy Provides a Non-Invasive Modality to Assess Driver Mutations and Tumor Heterogeneity in NSCLC
10:15 - 10:15 | Author(s): Vanessa Karen De Sa
- Abstract
Loading... -
+
P2.11-13 - What Is the Impact of Localised Data When Training Deep Neural Networks for Lung Cancer Prediction? (Now Available)
10:15 - 10:15 | Presenter: Anand Devaraj
- Abstract
Loading... -
+
P2.11-14 - Evolutionary Action Score of TP53 Predicts the Prognosis of Patients with Stage I Lung Adenocarcinoma
10:15 - 10:15 | Presenter: Yue Zhao
- Abstract
Loading... -
+
P2.11-15 - Detection of Circulating Genetically Abnormal Cells Improves the Diagnostic Accuracy in Lung Cancer Presenting with GGNs
10:15 - 10:15 | Presenter: Bin Zhang
- Abstract
Loading... -
+
P2.11-16 - Variability in Reading Low-Dose Chest CT: Individual Readers vs. Central Review in a Nationwide Lung Cancer Screening Project
10:15 - 10:15 | Presenter: Eui Jin Hwang
- Abstract
Loading... -
+
P2.11-17 - Analysis of Lung Adenocarcinoma EGFR Mutation by LAMP Method: Comparison with PCR Method and Identification of a Novel Exon19 Deletion Mutation (Now Available)
10:15 - 10:15 | Presenter: Sho Horiuchi
- Abstract
Loading... -
+
P2.11-18 - Circulating Serum KLK5 and L1CAM Levels Potentially Predict Clinical Outcome to Anlotinib Therapy in NSCLC Patients
10:15 - 10:15 | Presenter: Jun Lu
- Abstract
Loading... -
+
P2.11-19 - Effects of Incorporating a Lung Cancer Screening Educational Intervention into Tobacco Cessation Counseling (Now Available)
10:15 - 10:15 | Presenter: Dan J. Raz
- Abstract
Loading... -
+
P2.11-20 - Risk Factors of Lung Cancer Development in IPF Patients
10:15 - 10:15 | Presenter: Hye Seon Kang
- Abstract
Loading... -
+
P2.11-21 - Usefulness of Diffusion-Weighted Whole-Body Imaging with Background Suppression in the Postoperative Follow-up Period (Now Available)
10:15 - 10:15 | Presenter: Kanto Suemori
- Abstract
Loading... -
+
P2.11-22 - Comparison of the Sensitivity of USPSTF and PLCOm2012 Lung Cancer Screening Criteria in a Racially Diverse Population
10:15 - 10:15 | Presenter: Mary M. Pasquinelli
- Abstract
Loading... -
+
P2.11-23 - Performance of Lung Cancer Risk Prediction Models in I-ELCAP Smokers
10:15 - 10:15 | Presenter: Rowena Yip
- Abstract
Loading... -
+
P2.11-24 - The First Comprehensive Primary Care Provider Training for Lung Cancer Care in the U.S. - An Innovative Online Course
10:15 - 10:15 | Presenter: Celeste T Worth
- Abstract
Loading... -
+
P2.11-25 - Pre- and Post-Surgery Metabolomic Profiles in Early-Stage NSCLC Patients
10:15 - 10:15 | Presenter: Wannisa Laosuangkoon
- Abstract
Loading... -
+
P2.11-26 - Survival of Patients with Multiple Primaries and Single Lung Cancer - A Comparative Analysis (Now Available)
10:15 - 10:15 | Presenter: Anna Maria Romaszko-Wojtowicz
- Abstract
Loading... -
+
P2.11-27 - Early Detection of Lung Cancer: Optimal Strategies
10:15 - 10:15 | Presenter: Oleg Kshivets
- Abstract
Loading... -
+
P2.11-28 - Late-Breaking Abstract - Clinical Potential of Sputum Hyaluronan Measurement in the Diagnosis and Prognosis of Patients with NSCLC (Now Available)
10:15 - 10:15 | Author(s): Juliano Prudencio Chinoca
- Abstract
Loading... -
+
P2.11-29 - Diagnosis and Surveillance of Solitary Pulmonary Nodules with ctDNA Methylation Sequencing: Protocol for a Prospective Multicenter Study
10:15 - 10:15 | Presenter: Wenhua Liang
- Abstract
Loading... -
+
P2.11-30 - Effects of the Size of Nodules, Reconstruction Slice Thickness and Convolution Kernel on Radiomics Model in Classifying Pulmonary Nodules
10:15 - 10:15 | Presenter: Yan Xu
- Abstract
Loading... -
+
P2.11-31 - DNA Methylation Markers for Prediction of Recurrence in Stage I Non-Small Cell Lung Cancers (Now Available)
10:15 - 10:15 | Presenter: Yan Wang
- Abstract
Loading... -
+
P2.11-32 - Project ACTS (Adherence to CT Screening): Developing Patient Engagement Tools to Support Lung Cancer Screening Adherence
10:15 - 10:15 | Presenter: Upal Basu Roy
- Abstract
Loading... -
+
P2.11-33 - Organizational Readiness for Implementation of Lung Cancer Screening in a Veterans Affairs Healthcare System
10:15 - 10:15 | Presenter: Lucy B Spalluto
- Abstract
Loading... -
+
P2.11-34 - Application of Next-Generation Sequencing for Screening of Sputum Samples (Now Available)
10:15 - 10:15 | Presenter: Yuko Minami
- Abstract
Loading... -
+
P2.11-35 - Lung Cancer Screening Knowledge, Perceptions and Decision-Making Among African Americans
10:15 - 10:15 | Author(s): Yan Kwan Lau
- Abstract
Loading... -
+
P2.11-36 - The Role of FDG-PET Scans in Pre-Invasive Endobronchial Lesions (Now Available)
10:15 - 10:15 | Presenter: Illaa Smesseim
- Abstract
Loading... -
+
P2.11-37 - Low-Dose CT Lung Screening: Analysis of Risk Factors Related to Lung Cancer
10:15 - 10:15 | Presenter: Yujing Jin
- Abstract
Loading... -
+
P2.11-38 - Creating a Successful Multidisciplinary Conference for Review of Suspicious Lung Nodules
10:15 - 10:15 | Presenter: Debra Sue Dyer
- Abstract
Loading... -
+
P2.11-39 - Multimodal Monitoring of Patient-Derived Early-Stage Lung Adenocarcinoma with the Chicken Chorioallantoic Membrane System
10:15 - 10:15 | Presenter: Eva Jolanthe Koziolek
- Abstract
Loading... -
+
P2.11-40 - Integration of Individualized Tobacco Cessation Counseling in a Lung Cancer Screening Program
10:15 - 10:15 | Author(s): Patricia L Franklin
- Abstract
Loading... -
+
P2.11-41 - Improving Annual Adherence in a Community Based Lung Cancer Screening Program (Now Available)
10:15 - 10:15 | Presenter: Karen Alisa Braithwaite
- Abstract
Loading... -
+
P2.11-42 - A Prospective Multicenter Study to Assess Combined 6 Tumor Markers for Early Stage Lung Cancer in Patients with Lung Nodule (Now Available)
10:15 - 10:15 | Presenter: Xiuyi Zhi
- Abstract
Loading... -
+
P2.11-43 - Management of Pulmonary Nodules Detected on CT: Multicenter Collaborative Study in Nagasaki Prefecture
10:15 - 10:15 | Presenter: Shin Tsutsui
- Abstract
Loading... -
+
P2.11-44 - A Preliminary Study Investigating the Impact of Platelet on Circulating Tumor Cell Enumeration (Now Available)
10:15 - 10:15 | Author(s): Yu Chen
- Abstract
Loading... -
+
P2.11-45 - Economical Screening for Lung Cancer in a Developing Country - 5 Years Experience
10:15 - 10:15 | Presenter: Shanmugam Not given Sankarkumaru
- Abstract
Loading... -
+
P2.11-46 - Could Malignancies Diagnosed During Round 2 of Screening Be Worked Up Sooner?
10:15 - 10:15 | Author(s): Timor Kadir
- Abstract
No abstract available for this presentation
-
+
P2.12 - Small Cell Lung Cancer/NET
- Type: Poster Viewing in the Exhibit Hall
- Track: Small Cell Lung Cancer/NET
- Presentations: 8
- Now Available
- Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
-
+
P2.12-01 - Small Cell Lung Cancer (SCLC) Treatment and Survival in the UK: A REAL-Oncology Analysis from the I-O Optimise Initiative
10:15 - 10:15 | Author(s): Michael Snee
- Abstract
Loading... -
+
P2.12-02 - Intertumoral Heterogeneity in Small Cell Lung Carcinoma According to the Primary Tumor Versus Lymph Node Metastases Delineated by RNA Sequencing
10:15 - 10:15 | Presenter: Zsolt Megyesfalvi
- Abstract
Loading... -
+
P2.12-03 - Building and Validating a Lymphocyte Nadir Based Model to Predict Survival in Patients with Limited Stage-Small Cell Lung Cancer
10:15 - 10:15 | Author(s): Yishan Yu
- Abstract
Loading... -
+
P2.12-04 - CLEPSIDRA: A Phase II Trial Combining Iadademstat with Platinum-Etoposide in Platinum-Sensitive Relapsed SCLC Patients
10:15 - 10:15 | Author(s): Michael Ropacki
- Abstract
Loading... -
+
P2.12-05 - A Phase II Trial of Pembrolizumab With Chemotherapy in Metastatic or Unresectable High Grade Neuroendocrine Carcinoma (Now Available)
10:15 - 10:15 | Presenter: Robert A Ramirez
- Abstract
Loading... -
+
P2.12-06 - Factors of Importance for Survival After Platinum Re-Challenge in Platinum-Sensitive Small-Cell Lung Cancer Patients
10:15 - 10:15 | Author(s): Salomon Tendler
- Abstract
Loading... -
+
P2.12-07 - Phase I Study of Amrubicin and Cisplatin with Concurrent Thoracic Radiotherapy (TRT) in Limited-Disease Small Cell Lung Cancer (LD-SCLC)
10:15 - 10:15 | Presenter: Minoru Fukuda
- Abstract
Loading... -
+
P2.12-08 - Surprisingly Promising Tumor Control Rate of S1 Combination with Anlotinib with Refractory Relapsed SCLC Who Failed ≥ 2 Lines Chemotherapy (Now Available)
10:15 - 10:15 | Presenter: Haihua Yang
- Abstract
Loading... -
+
P2.12-09 - Phase 2 Study of Talazoparib Plus Low-Dose Temozolomide in Patients with Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer
10:15 - 10:15 | Author(s): Amy Lauren Cummings
- Abstract
Loading... -
+
P2.12-10 - The Circular RNA cESRP1 Sensitizes Small Cell Lung Cancer to Chemotherapy
10:15 - 10:15 | Presenter: Linlang Guo
- Abstract
Loading... -
+
P2.12-11 - Quality of Life in ALTER1202 Trial of Anlotinib as Third-or Further Line Therapy for Advanced Small Cell Lung Cancer (SCLC): A Post-Hoc Analysis
10:15 - 10:15 | Presenter: Kai Li
- Abstract
Loading... -
+
P2.12-12 - Nomograms to Predict Survival in Patients with Limited Stage Small Cell Lung Cancer Treated with Definitive Chemoradiotherapy (Now Available)
10:15 - 10:15 | Presenter: Junmiao Wen
- Abstract
Loading... -
+
P2.12-13 - Lurbinectedin (L) Combined with Paclitaxel (P) or Irinotecan (I) in Relapsed SCLC. Results from Two Phase Lb Trials
10:15 - 10:15 | Presenter: Santiago Ponce
- Abstract
Loading... -
+
P2.12-14 - A Pilot Study of Serial Plasma Metabolomics in Small Cell Lung Cancer Patients
10:15 - 10:15 | Presenter: Se-Hoon Lee
- Abstract
Loading... -
+
P2.12-15 - The Role of Surgery in Patients with Small Cell Lung Cancer: A Period Propensity Score Matching Analysis of the SEER Database, 2010-2015
10:15 - 10:15 | Presenter: Xiaojun Du
- Abstract
Loading... -
+
P2.12-16 - Changes of Peripheral Blood sPD-L1 in Patients with Small Cell Lung Cancer During Chemotherapy and Its Clinical Significance (Now Available)
10:15 - 10:15 | Presenter: Hao Tian
- Abstract
Loading... -
+
P2.12-17 - Treatment Patterns in Small Cell Lung Cancer (SCLC): An Observational Study of 2016–2018 EHR Data
10:15 - 10:15 | Presenter: Katarina Öhrling
- Abstract
Loading... -
+
P2.12-18 - Prevalence of DLL3 Expression and Its Prognostic Role in Extensive Stage Small Cell Lung Cancer (Now Available)
10:15 - 10:15 | Author(s): seungtaek Lim
- Abstract
Loading... -
+
P2.12-19 - Small Cell Lung Cancer (SCLC) Treatment and Survival in Portugal: An IPO-PORTO Analysis from the I-O Optimise Initiative
10:15 - 10:15 | Presenter: Marta Soares
- Abstract
Loading... -
+
P2.12-20 - NRG Oncology/Alliance LU005: A Phase II/III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab in LS-SCLC (Now Available)
10:15 - 10:15 | Presenter: Kristin A Higgins
- Abstract
Loading... -
+
P2.12-21 - Outcomes with Immune Checkpoint Inhibitors (ICI) for Relapsed Small Cell Lung Cancer (SCLC) in a Swiss Cohort
10:15 - 10:15 | Presenter: Laetitia Arja Mauti
- Abstract
Loading... -
+
P2.12-22 - Risk Factors for BM Incidence in SCLC: A Predictive Model for SCLC Patients on Brain Metastasis (Now Available)
10:15 - 10:15 | Presenter: Jiexia Zhang
- Abstract
Loading... -
+
P2.12-23 - Radiological Features of SCLC-Like and NSCLC-Like Large Cell Neuroendocrine Carcinoma (LCNEC)
10:15 - 10:15 | Presenter: Bregtje Catharina Maria Hermans
- Abstract
Loading... -
+
P2.12-24 - Underutilization of Surgery for Localized Small Cell Lung Cancer: A Nationwide Analysis
10:15 - 10:15 | Presenter: Kaushal Parikh
- Abstract
Loading... -
+
P2.12-25 - Surgical Management of Pulmonary Carcinoid ≤3cm: Extent of Resection and Lymph Nodes Examination (Now Available)
10:15 - 10:15 | Presenter: Yang Wo
- Abstract
Loading... -
+
P2.12-26 - The Impact of Anlotinib for Relapsed SCLC Patients with Brain Metastases: A Subgroup Analysis of ALTER 1202
10:15 - 10:15 | Presenter: Ying Cheng
- Abstract
Loading...
-
+
P2.13 - Staging
- Type: Poster Viewing in the Exhibit Hall
- Track: Staging
- Presentations: 7
- Now Available
- Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
-
+
P2.13-01 - PET-CT Underestimates Unexpected pN2 in Lung Adenocarcinoma (Now Available)
10:15 - 10:15 | Presenter: Samuel Garcia-Reina
- Abstract
Loading... -
+
P2.13-02 - Persistent Occult Micrometastases in Mediastinal Lymph Nodes Are Associated with Reduced Survival After Neoadjuvant Therapy
10:15 - 10:15 | Presenter: Paweł Gwóźdź
- Abstract
Loading... -
+
P2.13-03 - Is It Time to Replace Cervical Mediastinoscopy with EBUS-FNAC in Invasive Mediastinal Staging for NSCLC?
10:15 - 10:15 | Presenter: Virendra Kumar Tiwari
- Abstract
Loading... -
+
P2.13-04 - Molecular Nodal Restaging Based on Embryonic Markers Expression Adds No Relevant Clinical Information in Resected Lung Cancer
10:15 - 10:15 | Presenter: Ivan Macia
- Abstract
Loading... -
+
P2.13-05 - Endobronchial Ultrasound for Mediastinal Restaging in Non-Small Cell Lung Cancer (Now Available)
10:15 - 10:15 | Presenter: Sonia Baeza Mena
- Abstract
Loading... -
+
P2.13-06 - Finding a Place for Pathological Near Complete Response Patients Following Neoadjuvant/Induction Therapy in the TNM Staging
10:15 - 10:15 | Presenter: Hüseyin Melek
- Abstract
Loading... -
+
P2.13-07 - CT Staging for Suspected Lung Cancer; Should We Routinely Image the Pelvis?
10:15 - 10:15 | Presenter: Elizabeth Eleanor Barclay
- Abstract
Loading... -
+
P2.13-08 - Which Is the Reliable Prognosticator for Early Metastasis and Recurrence of Non- Small Cell Lung Cancer, Related with STAS?
10:15 - 10:15 | Presenter: Soo-Youn Ham
- Abstract
Loading... -
+
P2.13-09 - The Impact of the 8th Edition of IASLC Staging in Patients Who Underwent Surgical Treatment of Lung Cancer (Now Available)
10:15 - 10:15 | Author(s): Pedro Henrique Cunha Leite
- Abstract
Loading... -
+
P2.13-10 - Lymph Node Upstaging Evaluation After Robotic Resection for NSCLC in Brazil (Now Available)
10:15 - 10:15 | Presenter: Ricardo Mingarini Terra
- Abstract
Loading... -
+
P2.13-11 - Predicting Micrometastasis in Mediastinal Lymph Nodes in Patients with Non-Small Cell Lung Cancer (Now Available)
10:15 - 10:15 | Presenter: Suat Erus
- Abstract
Loading... -
+
P2.13-12 - Endobronchial Ultrasound for Diagnosis and Staging of Lung Cancer: Our Experience (Now Available)
10:15 - 10:15 | Presenter: Angela 3355399488 De Palma
- Abstract
Loading... -
+
P2.13-14 - The Utility of Three-Dimensional CT for Prediction of Tumor Invasiveness in Clinical IA Lung Acenocarcinoma (Now Available)
10:15 - 10:15 | Presenter: Yohei Kawaguchi
- Abstract
Loading...
-
+
P2.14 - Targeted Therapy
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
- Presentations: 19
- Now Available
- Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
-
+
P2.14-01 - Real World Treatment Outcomes in Chinese Patients with RET-Rearranged Lung Cancer
10:15 - 10:15 | Presenter: Lu Yang
- Abstract
Loading... -
+
P2.14-02 - Interim Survival Analysis of Gefitinib Plus Vinorelbine in Advanced EGFR-Mutant Non-Small Cell Lung Cancer (Genoa Trial)
10:15 - 10:15 | Presenter: Carlo Genova
- Abstract
Loading... -
+
P2.14-03 - Predictive Factors of Osimertinib as Salvage Treatment for Metastatic EGFR T790M Positive Lung Adenocarcinoma (Now Available)
10:15 - 10:15 | Presenter: Seung Hun Jang
- Abstract
Loading... -
+
P2.14-04 - Clinical Validation of Large NGS Gene Panel Using Residual Specimen (Now Available)
10:15 - 10:15 | Presenter: Tomohiro Sakamoto
- Abstract
Loading... -
+
P2.14-05 - EGFR Mutation Status and Prognostic Impact in Patients with Surgically Resected Lung Adenocarcinoma (Now Available)
10:15 - 10:15 | Presenter: Yoshimasa Tokunaga
- Abstract
Loading... -
+
P2.14-06 - The Study of Rac3 Molecular Mechanism Through ERK Signaling Pathway in Lung Adenocarcinoma
10:15 - 10:15 | Author(s): JINGHAN Li
- Abstract
Loading... -
+
P2.14-07 - Efficacy of Single Bevacizumab Intrapleural or Intrapericardial Injection in the Treatment of Lung Cancer-Mediated Malignant Effusion
10:15 - 10:15 | Presenter: Dongyun He
- Abstract
Loading... -
+
P2.14-08 - Banf1 Predicts Lung Cancer Survival and Sensitivity to Platinum-Based Chemotherapy
10:15 - 10:15 | Author(s): Jennifer Plowman
- Abstract
Loading... -
+
P2.14-09 - Concurrent TP53 Mutation Adversely Impact the Efficacy of Crizotinib in ROS1-Rearranged Lung Cancer Patients
10:15 - 10:15 | Presenter: Gen Lin
- Abstract
Loading... -
+
P2.14-10 - Identification of Frequent, Activating HER2 Mutations and HER2 Inhibitor Response and Resistance in Canine Lung Cancer (Now Available)
10:15 - 10:15 | Author(s): Gwendolen Lorch
- Abstract
Loading... -
+
P2.14-11 - Retreatment with EGFR-TKI for 541 NSCLC Patients with EGFR Mutation
10:15 - 10:15 | Presenter: Kosuke Takahashi
- Abstract
Loading... -
+
P2.14-12 - Tyrosine Kinase Inhibitor Resistance Mechanisms in EGFR T790M-Positive Lung Cancer: The University of Chicago Experience
10:15 - 10:15 | Presenter: Garth William Strohbehn
- Abstract
Loading... -
+
P2.14-13 - Elevated Expression of Eukaryotic Translation Initiation Factor 3 Subunit C Contributes to EGFR-TKI Resistance in Lung Adenocarcinoma
10:15 - 10:15 | Presenter: Takuya Shintani
- Abstract
Loading... -
+
P2.14-14 - Comparison of Molecular Testing Modalities for Detection of NRG1 Rearrangements in Invasive Mucinous Adenocarcinoma
10:15 - 10:15 | Author(s): Domenico Trombetta
- Abstract
Loading... -
+
P2.14-15 - Impact of Coexisting Gene Mutations in EGFR-Mutated Non–Small Cell Lung Cancer Before Treatment on EGFR T790M Mutation Status After EGFR-TKIs
10:15 - 10:15 | Presenter: Masayuki Takeda
- Abstract
Loading... -
+
P2.14-16 - T790M or C797S Confers Acquired Resistance to Tarloxotinib and Poziotinib in EGFR Exon 20 Insertion-Driven Lung Cancer Models in Vitro
10:15 - 10:15 | Presenter: Kenichi Suda
- Abstract
Loading... -
+
P2.14-17 - Correlation Between Clinic-Pathological Data and T790M Detection in EGFR Mutated NSCLC Patients Progressing on 1st/2nd Generation TKIs (Now Available)
10:15 - 10:15 | Author(s): Daniele Pignataro
- Abstract
Loading... -
+
P2.14-18 - Upregulation of AURKA Leads to Acquired Resistance in EML4-ALK NSCLC Cell Line
10:15 - 10:15 | Presenter: Ganesh Umapathy
- Abstract
Loading... -
+
P2.14-19 - Notch3 and β-Catenin Are Frequently Co-Expressed in EGFR Mutant NSCLC
10:15 - 10:15 | Presenter: Rajeswara Rao Arasada
- Abstract
Loading... -
+
P2.14-20 - ATORG-003: Dacomitinib With or Without Dose Titration as First-Line Therapy for Metastatic EGFR Mutant Non-Small Cell Lung Cancer (NSCLC)
10:15 - 10:15 | Presenter: Aaron C Tan
- Abstract
Loading... -
+
P2.14-21 - Liquid Biopsy in Lung Cancer: Comparison Between Real-Time PCR and MALDI-TOF for ctDNA Molecular Profiling (Now Available)
10:15 - 10:15 | Presenter: Pierre-Jean Lamy
- Abstract
Loading... -
+
P2.14-22 - Loss of Ect2 Expression Impairs Cell-Matrix Adhesion and FAK/Src Signaling in Lung Adenocarcinoma Cells
10:15 - 10:15 | Presenter: Zeinab Kosibaty
- Abstract
Loading... -
+
P2.14-23 - Initial Analysis in NSCLC Part of Randomized Trial Evaluating Topical Corticosteroid for the Facial Acneiform Rash by EGFR Inhibitors (Now Available)
10:15 - 10:15 | Presenter: Yutaka Fujiwara
- Abstract
Loading... -
+
P2.14-24 - An Open-Label Randomized Phase II Study of Combining Osimertinib With and Without Ramucirumab in TKI-Naïve EGFR-Mutant Metastatic NSCLC
10:15 - 10:15 | Presenter: Xiuning Le
- Abstract
Loading... -
+
P2.14-25 - Lorlatinib Induced Protective Autophagy via the AKT–mTOR Pathway in ALK- Rearrangement Lung Cancer Cells (Now Available)
10:15 - 10:15 | Presenter: Conghua Lu
- Abstract
Loading... -
+
P2.14-26 - Outcomes in Patients with Compound Epidermal Growth Factor Receptor (EGFR) Mutations After Treatment with Tyrosine Kinase Inhibitors (TKIs)
10:15 - 10:15 | Presenter: Sean Breslin
- Abstract
Loading... -
+
P2.14-27 - Efficacy and Prognostic Factor of Apatinib Plus EGFR-TKI in Treating Advanced Non-Small-Cell Lung Cancer with EGFR-TKI Resistance
10:15 - 10:15 | Presenter: Guilan Dong
- Abstract
Loading... -
+
P2.14-28 - Real-World Management and Outcomes of Uncommon EGFR Mutation-Positive NSCLC Patients at Two Tertiary Canadian Cancer Centres (Now Available)
10:15 - 10:15 | Author(s): Roxana A Tudor
- Abstract
Loading... -
+
P2.14-29 - Clinical Impact of Next-Generation Sequencing (NGS) in Blood Liquid Biopsies for Treatment Decisions in Advanced NSCLC
10:15 - 10:15 | Author(s): MIGUEL Garcia Pardo
- Abstract
Loading... -
+
P2.14-30 - Predictive Value of ctDNA in Patients with EGFR Positive NSCLC Receiving 3rd Generation TKI
10:15 - 10:15 | Author(s): Fedor Vladimirovich Moiseenko
- Abstract
Loading... -
+
P2.14-31 - Melatonin Inhibits Proliferation and Invasion Through Downregulating CircRNA NID1 in Non-Small Cell Lung Cancer Cells (Now Available)
10:15 - 10:15 | Author(s): Yuanyong Wang
- Abstract
Loading... -
+
P2.14-32 - Epigenetic Silencing of SPARC in NSCLCs
10:15 - 10:15 | Presenter: Federico Pio Fabrizio
- Abstract
Loading... -
+
P2.14-33 - An Open-Label PET-MRI Study to Determine Brain Exposure of Osimertinib in Patients with EGFR Mutant NSCLC and CNS Metastases
10:15 - 10:15 | Presenter: Simon Ekman
- Abstract
Loading... -
+
P2.14-34 - Tyrosine-Kinase Inhibitors (TKI) in First-Line Treatment of 470 Patients with Non-Small Cell Lung Cancer (NSCLC) from the Czech Republic
10:15 - 10:15 | Presenter: Jana Skřičková
- Abstract
Loading... -
+
P2.14-35 - 2-Deoxy-D-Glucose Sensitizes Non-Small Cell Lung Cancer with EML4-ALK Fusion to Crizotinib via Suppression of HK2 Through AKT/mTOR Passway
10:15 - 10:15 | Presenter: Caiyu Lin
- Abstract
Loading... -
+
P2.14-36 - Identification of Genomic Features in Tumor-Derived Organoids from Resectable NSCLC (Now Available)
10:15 - 10:15 | Presenter: Jing-Hua Chen
- Abstract
Loading... -
+
P2.14-37 - Anaplastic Lymphoma Kinase Inhibitor Induced Pneumonitis in Patients with NSCLC: Clinical and Radiologic Characteristics and Risk Factors
10:15 - 10:15 | Presenter: Mi Young Kim
- Abstract
Loading... -
+
P2.14-38 - ATAD2B-ALK, a Novel Fusion in Lung Adenocarcinoma Identified Using Next-Generation Sequencing (NGS) (Now Available)
10:15 - 10:15 | Author(s): Huiwen Bai
- Abstract
Loading... -
+
P2.14-39 - Effects of Renal Function on Lorlatinib Safety and Pharmacokinetics
10:15 - 10:15 | Presenter: Swan Lin
- Abstract
Loading... -
+
P2.14-40 - Tumor-Stromal Microenvironment Interactions in a PDX Model of EGFR TKI Drug Tolerance
10:15 - 10:15 | Presenter: Erin L Stewart
- Abstract
Loading... -
+
P2.14-41 - Risk Factors for Brain Metastasis in Patients with EGFR Mutant Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Takehiro Tozuka
- Abstract
Loading... -
+
P2.14-42 - Emergence of CCDC6-RET Fusion with Maintained EGFR T790M Mutation After Resistance to Osimertinib in NSCLC: A Case Report
10:15 - 10:15 | Author(s): Rongyun Guo
- Abstract
Loading... -
+
P2.14-43 - Cost-Effectiveness of 1st-Line Treatment EGFR-TKIs for Advanced NSCLC Patients Harboring EGFR Mutation in Mexico (Now Available)
10:15 - 10:15 | Presenter: Laura Alejandra Ramírez Ramírez Tirado
- Abstract
Loading... -
+
P2.14-44 - Tumor Mutation Burden and Efficacy of Molecular Targeted Therapy in Lung Cancer
10:15 - 10:15 | Presenter: Katsunori Arai
- Abstract
Loading... -
+
P2.14-45 - EML4-ALK Fusion Subtype Is Associated with Therapeutic Efficacy in Advanced Non-Small Cell Lung Cancer (Now Available)
10:15 - 10:15 | Presenter: Huijuan Wang
- Abstract
Loading... -
+
P2.14-46 - Treatment Observations and Clinical Experience with Lorlatinib in Pretreated ALK and ROS1 Rearranged NSCLC Patients
10:15 - 10:15 | Presenter: Maximilian J. Hochmair
- Abstract
Loading... -
+
P2.14-47 - Real-World Multicenter Experience of First-line Afatinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Chong Kin Liam
- Abstract
Loading... -
+
P2.14-48 - Clinical Sequencing Using a NGS-Based Multiple Gene Assay in Patients with Non-Small Cell Lung Cancer
10:15 - 10:15 | Author(s): Yuki Gao
- Abstract
Loading... -
+
P2.14-49 - Molecular Characteristics of HER2 Mutations in Non-Small Cell Lung Cancer (Now Available)
10:15 - 10:15 | Presenter: Xuewu Wei
- Abstract
Loading... -
+
P2.14-50 - Low Temperature Plasma Needle Induces Cell Cycle Arrest of Epithelial Lung Cancer Cells in Vitro via a p21-Dependent Pathway (Now Available)
10:15 - 10:15 | Presenter: Milena Cavic
- Abstract
Loading... -
+
P2.14-51 - Dual ALK Fusion Partners as Poor Predictive Marker in First Line Crizotinib Treated ALK Rearranged Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Yongchang Zhang
- Abstract
Loading... -
+
P2.14-52 - The Results from Plasma EGFR Mutation Analysis in NEJ026 Study
10:15 - 10:15 | Presenter: Tatsuro Fukuhara
- Abstract
Loading... -
+
P2.14-53 - High MET Overexpression Does Not Predict the Presence of MET Exon 14 Splice Mutations in NSCLC: Results from the IFCT Predict.amm Study
10:15 - 10:15 | Presenter: Simon Baldacci
- Abstract
Loading... -
+
P2.14-54 - High Incidence of CNS Metastases in Advanced or Recurrent Non-Small Cell Lung Cancer Patients with RET Fusion
10:15 - 10:15 | Presenter: Jiyun Lee
- Abstract
Loading... -
+
P2.14-55 - Real-World Safety and Efficacy Data of Osimertinib in Patients from Japan with EGFR T790M-Positive NSCLC
10:15 - 10:15 | Presenter: Yuichiro Ohe
- Abstract
Loading... -
+
P2.14-56 - Osimertinib Overcomes Alectinib Resistance Caused by Amphiregulin in a Leptomeningeal Carcinomatosis Model of EML4-ALK Lung Cancer
10:15 - 10:15 | Presenter: Sachiko Arai
- Abstract
Loading... -
+
P2.14-57 - Efficacy of 3rd Generation EGFR-TKIs After Failing First or Second Generation EGFR-TKIs in EGFR Mutation-Positive NSCLC (ROOT-EGFR)
10:15 - 10:15 | Presenter: Hyun Ae Jung
- Abstract
Loading... -
+
P2.14-58 - A Phase IIIb, Open-Label Study of Afatinib in Caucasian EGFR TKI-Naïve Patients with EGFRm+ NSCLC: An Interim Analysis
10:15 - 10:15 | Author(s): Filippo De Marinis
- Abstract
Loading... -
+
P2.14-59 - Osimertinib in EGFR T790M Advanced NSCLC: Analysis of Uncommon/Complex EGFR Mutations in a Real-World Study (ASTRIS)
10:15 - 10:15 | Presenter: Parneet K Cheema
- Abstract
Loading... -
+
P2.14-60 - Afatinib in EGFR Mutation-Positive NSCLC: Activity in Patients with Brain Metastases, and Impact on CNS Progression/Spread
10:15 - 10:15 | Presenter: Kenneth John O’Byrne
- Abstract
Loading... -
+
P2.14-61 - Acquired Resistance to Entrectinib Associated with Activation of RAS Signaling Pathway in ROS1-Rearranged Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Bo Mi Ku
- Abstract
Loading... -
+
P2.14-62 - Early, Subclinical SCLC Transformation in Patients with EGFR Mutant Lung Cancer Receiving Osimertinib, Detected Through Cell-Free DNA
10:15 - 10:15 | Presenter: Erin L Stewart
- Abstract
Loading... -
+
P2.14-63 - Cost Analysis of the Management of CNS Metastases in Patients with Advanced ALK+ NSCLC: Alectinib vs Crizotinib
10:15 - 10:15 | Presenter: Bartomeu Massuti
- Abstract
Loading... -
+
P2.14-64 - Is ALK Inhibitor a Contraindication for Subsequent IVF Pregnancy?
10:15 - 10:15 | Presenter: Roni Gillis
- Abstract
Loading... -
+
P2.14-65 - Efficacy of Dabrafenib Plus Trametinib Combination in Patients with BRAF V600E–Mutant NSCLC in Real World Setting
10:15 - 10:15 | Presenter: Jean Bernard Auliac
- Abstract
Loading... -
+
P2.14-66 - Combination ALK and MEK Inhibition in ALK-Positive Lung Cancer
10:15 - 10:15 | Presenter: John Clive Ashton
- Abstract
Loading... -
+
P2.14-67 - Metastatic RET-Rearranged Lung Adenocarcinomas Treated with Alectinib: Retrospective Analysis of a Single Institution (Now Available)
10:15 - 10:15 | Presenter: Maurício Fernando Silva Almeida Ribeiro
- Abstract
Loading... -
+
P2.14-68 - Dramatical Intracranial Response to Osimertinib in Patient Harbouring the Uncommum EGFR G719S/L861Q Mutation (Now Available)
10:15 - 10:15 | Presenter: João Victor Machado Alessi
- Abstract
Loading... -
+
P2.14-69 - Lorlatinib Rescue Therapy for Life Threatening CNS Disease in Crizotinib-Resistant ROS1-Positive Non–Small Cell Lung Cancer (NSCLC) (Now Available)
10:15 - 10:15 | Presenter: Aaron John Franke
- Abstract
Loading...
-
+
P2.15 - Thymoma/Other Thoracic Malignancies
- Type: Poster Viewing in the Exhibit Hall
- Track: Thymoma/Other Thoracic Malignancies
- Presentations: 6
- Now Available
- Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
-
+
P2.15-01 - Surgical Resection of 61 Cases of Inflammatory Myofibroblastic Tumor of the Lung
10:15 - 10:15 | Presenter: Jun Zhang
- Abstract
Loading... -
+
P2.15-02 - Primary Salivary Gland-Type Lung Tumours, Surgically Treatable Rare Entity Lung Cancer: A Sixteen-Year Experience of a Single Centre (Now Available)
10:15 - 10:15 | Presenter: Sara Ricciardi
- Abstract
Loading... -
+
P2.15-03 - Tropomyosin-Related Kinase B Can Be a Biomarker of Prognosis and Therapeutic Target for Malignant Thymic Epithelial Tumors
10:15 - 10:15 | Presenter: Keigo Ozono
- Abstract
Loading... -
+
P2.15-04 - Impact of Prognostic Nutritional Index on Long-Term Outcomes After Surgery for Pulmonary Metastasis from Colorectal Cancer
10:15 - 10:15 | Presenter: Masahiro Yanagiya
- Abstract
Loading... -
+
P2.15-05 - Investigation of the Trans-Subxiphoid Robotic Thymectomy (Now Available)
10:15 - 10:15 | Presenter: Hiroki Numanami
- Abstract
Loading... -
+
P2.15-06 - Pretreatment Neutrophil to Lymphocyte Ratio Predicts Survival in Thymic Carcinoma Patients
10:15 - 10:15 | Presenter: Yang Zhao
- Abstract
Loading... -
+
P2.15-07 - Bimanual Examination Is Indispensable in the Surgery of Lung Metastatic Tumors! (Now Available)
10:15 - 10:15 | Author(s): Yusuf Kahya
- Abstract
Loading... -
+
P2.15-08 - Multicenter Experience with Complete Surgical Resection of Primary Pulmonary Artery Sarcoma (Now Available)
10:15 - 10:15 | Presenter: Edward Y. Chan
- Abstract
Loading... -
+
P2.15-09 - Clinical Features and Prognosis of Primary Tracheal Cancer at Our Institution’s Experience
10:15 - 10:15 | Presenter: Yoshiyuki Mishina
- Abstract
Loading... -
+
P2.15-10 - Clinical Significance of Age at Diagnosis Among Patients with Thymic Epithelial Tumor (Now Available)
10:15 - 10:15 | Presenter: Mina Liu
- Abstract
Loading... -
+
P2.15-11 - Favorable Long Term Survival After Initially Palliative Resection for a Giant Primary Rib Osteosarcoma with Severe Mediastinal Shifting (Now Available)
10:15 - 10:15 | Presenter: Katharina Sinn
- Abstract
Loading... -
+
P2.15-12 - Epidemiology of Thymic Epithelial Tumors: 22-Year Experience from a Single-Institution
10:15 - 10:15 | Presenter: Patricia Rioja
- Abstract
Loading... -
+
P2.15-13 - The Role of Adjuvant Therapy for Atypical Bronchopulmonary Carcinoids: A Population-Based Analysis
10:15 - 10:15 | Presenter: Rodney Ervin Wegner
- Abstract
Loading...
-
+
P2.16 - Treatment in the Real World - Support, Survivorship, Systems Research
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
- Presentations: 17
- Now Available
- Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
-
+
P2.16-01 - Risk Factors for Short-Term Post-Operative Events Following Lung Cancer Resection
10:15 - 10:15 | Presenter: Wil Lieberman-Cribbin
- Abstract
Loading... -
+
P2.16-02 - Randomising Patients into Trials of Thoracic Cancer Surgery: An Analysis of Patient and Cancer Team Behaviour in Practice (Now Available)
10:15 - 10:15 | Author(s): Tom Treasure
- Abstract
Loading... -
+
P2.16-03 - IELCART Quality of Life in the First Year After Surgery for Stage IA Lung Cancer Patients: Preliminary Results
10:15 - 10:15 | Presenter: Esther Fevrier
- Abstract
Loading... -
+
P2.16-04 - Single-Port Video-Assisted Thoracoscopic Surgery Reduces Patient-Reported Symptom Burden in Patients Undergoing Lung Resection (Now Available)
10:15 - 10:15 | Author(s): Wei Dai
- Abstract
Loading... -
+
P2.16-05 - Population-Based ROS1 Testing in Lung Cancer: Creating Opportunity in a Publicly Funded System
10:15 - 10:15 | Presenter: Maisam Makarem
- Abstract
Loading... -
+
P2.16-06 - Molecular Features and Treatment Outcome of HER2 Mutated Advanced Non-Small Cell Lung Cancer Patients in China
10:15 - 10:15 | Author(s): Yan Wang
- Abstract
Loading... -
+
P2.16-07 - How to Manage Toxicities of EGFR-TKI for Extreme Elderly Lung Cancer Patients: Supportive Care for Patients Aged 85 and Older
10:15 - 10:15 | Presenter: Yoshitaka Seki
- Abstract
Loading... -
+
P2.16-08 - Clinical Characteristics and Outcomes of Patients with BRAF Mutated Non-Small Cell Lung Cancer (Now Available)
10:15 - 10:15 | Presenter: Yuxin Mu
- Abstract
Loading... -
+
P2.16-09 - Real-World Brigatinib Use in Non-Small Cell Lung Cancer Patients with Prior Use of Crizotinib/Other ALK Therapies in the US
10:15 - 10:15 | Presenter: Huamao Mark Lin
- Abstract
Loading... -
+
P2.16-10 - Advances in Diagnosis and Treatment of Non-Small Cell Lung Cancer Are Translating into Real-World Survival Gains in the United States
10:15 - 10:15 | Presenter: Oladimeji Akinboro
- Abstract
Loading... -
+
P2.16-11 - ADVANCE-1: Development and Feasibility Testing of a Benchmarking Approach for Quality Improvement in Lung Cancer Care (Now Available)
10:15 - 10:15 | Presenter: Brendan McCann
- Abstract
Loading... -
+
P2.16-12 - Treatment Uptake and Outcomes of Elderly Stage III NSCLC Patients: A 15-Year Retrospective Real-World Study (Now Available)
10:15 - 10:15 | Presenter: Amanda Jane Williams Gibson
- Abstract
Loading... -
+
P2.16-13 - Risk Factors of Radiation Pneumonitis in Lung Cancer Patients with Subclinical Interstitial Lung Disease After Thoracic Radiotherapy
10:15 - 10:15 | Presenter: Fangjuan Li
- Abstract
Loading... -
+
P2.16-14 - Survival Rates in Non-Small Cell Lung Cancer Patients in the Brazilian Private Health System: A Cohort Study
10:15 - 10:15 | Author(s): Erica Cerqueira
- Abstract
Loading... -
+
P2.16-15 - Survival and Clinical Immunotherapy Outcomes in Hispanic Patients vs Non-Hispanic White Patients with Non-Small Cell Lung Cancer (Now Available)
10:15 - 10:15 | Presenter: Luis Raez
- Abstract
Loading... -
+
P2.16-16 - Calf Circumference Is Associated with Postoperative Outcomes in Lung Cancer Patients Who Underwent Surgery (Now Available)
10:15 - 10:15 | Presenter: Akihiro Nagoya
- Abstract
Loading... -
+
P2.16-17 - Real-World Trends in Systemic Therapy for Nonsquamous EGFR/ALK-Negative Advanced NSCLC (aNSCLC) in the US, 2011–2018
10:15 - 10:15 | Presenter: Vamsidhar Velcheti
- Abstract
Loading... -
+
P2.16-18 - Opioid-Induced Constipation in Patients with Cancer Pain in Japan (OIC-J study): A Post-Hoc Analysis of Lung Cancer Patients
10:15 - 10:15 | Presenter: Hisao Imai
- Abstract
Loading... -
+
P2.16-19 - Real World Data in Non-Small Cell Lung Cancer with Activating EGFR Mutation - A Multicenter Observational Study
10:15 - 10:15 | Presenter: Madoka Kimura
- Abstract
Loading... -
+
P2.16-20 - Big Data and Survival Predictors in Lung Cancer Patients
10:15 - 10:15 | Presenter: Beatriz Núñez-García
- Abstract
Loading... -
+
P2.16-21 - Effects of Molecular Markers on Responses, Relapses, and Survival in Lung Cancer Patients with HIV (Now Available)
10:15 - 10:15 | Presenter: Neha K Reddy
- Abstract
Loading... -
+
P2.16-22 - Predictive Analytic of Survival Using a Neural Network in a Real World Cohort of Advanced Non Small Cell Lung Cancer Patients (Now Available)
10:15 - 10:15 | Presenter: Luis Eduardo Pino
- Abstract
Loading... -
+
P2.16-23 - Rates of Support and Care Offerings Among Patients in an Advocacy Organization Sponsored Lung Cancer Patient Registry
10:15 - 10:15 | Presenter: Andrew Ciupek
- Abstract
Loading... -
+
P2.16-24 - Prognostic Value of RDW, NLR and CYFRA 21-1 in Overall Survival of Patients with Metastatic NSCLC (Now Available)
10:15 - 10:15 | Presenter: Claudio J. Flores
- Abstract
Loading... -
+
P2.16-25 - Epidemiology of Advanced Lung Cancer in Peru
10:15 - 10:15 | Author(s): Rossana Ruiz
- Abstract
Loading... -
+
P2.16-26 - Opportunity of WBRT in EGFR-Mutated Lung Adenocarcinoma Patients with Multiple Brain Metastases: A Retrospective Study Based on DS-GPA (Now Available)
10:15 - 10:15 | Presenter: Jindong Guo
- Abstract
Loading... -
+
P2.16-27 - Longitudinal Skeletal Muscle Changes in Patients with Advanced Squamous Cell Lung Cancer
10:15 - 10:15 | Presenter: Young Saing Kim
- Abstract
Loading... -
+
P2.16-28 - Retrospective Analysis of Patients with Previous Extrathoracic Malignancies After Resection of Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Ami Wada
- Abstract
Loading... -
+
P2.16-29 - Lung Cancer in Lleida: An Epidemiologic Study (Now Available)
10:15 - 10:15 | Presenter: Joel Veas
- Abstract
Loading... -
+
P2.16-30 - Real World Data of Targeted Therapy Versus Chemotherapy Maintenance Among Patients with III-IV Clinical Stage Lung Cancer at Oncosalud – AUNA
10:15 - 10:15 | Presenter: Alfredo Aguilar
- Abstract
Loading... -
+
P2.16-31 - Immunotherapy in the Regional Setting: Real World Experience of Outcome and Toxicity
10:15 - 10:15 | Presenter: Mike Nguyen
- Abstract
Loading... -
+
P2.16-32 - Best Supportive Care for Extreme Elderly Lung Cancer Patients
10:15 - 10:15 | Presenter: Taisuke Kazuyori
- Abstract
Loading... -
+
P2.16-33 - What Influences Patient Decision-Making About Lung-Cancer Treatment? A Discrete Choice Experiment (Now Available)
10:15 - 10:15 | Presenter: Fiona Hegi-Johnson
- Abstract
Loading... -
+
P2.16-34 - Is Prophylactic Cranial Irradiation Useful in Real World? (Now Available)
10:15 - 10:15 | Author(s): Raquel Gómez Bravo
- Abstract
Loading... -
+
P2.16-35 - Factors Associated with Prolonged Postoperative Hospital Stay in Patients Undergoing Lung Cancer Surgery
10:15 - 10:15 | Presenter: Wei Dai
- Abstract
Loading... -
+
P2.16-36 - Patterns of Care in a Prospective Clinical Cohort of Patients with Lung Cancer - Preliminary Analyses from the EnRICH Program
10:15 - 10:15 | Presenter: Bea Brown
- Abstract
Loading... -
+
P2.16-37 - Impact of Brain Metastases on Healthcare Utilisation and Costs in Patients with NSCLC Treated with EGFR-TKIs
10:15 - 10:15 | Presenter: Deepa S Subramaniam
- Abstract
Loading... -
+
P2.16-38 - Efficacy and Safety of Target Therapy and Immunotherapy in Advanced NSCLC in Elderly: A Systematic Review of Real World Studies
10:15 - 10:15 | Presenter: Tindara Franchina
- Abstract
Loading... -
+
P2.16-39 - The Association Between Dietary Protein Intake and the Risk of Lung Cancer: A Meta-Analysis
10:15 - 10:15 | Author(s): Xiaofeng Li
- Abstract
Loading... -
+
P2.16-40 - Acknowledging Social and Economic Inequities Experienced by Canada's Inuit: Implications for Diagnosis and Treatment of Lung Cancer (Now Available)
10:15 - 10:15 | Presenter: Chantal Bornais
- Abstract
Loading... -
+
P2.16-41 - Pembrolizumab for Previously Treated, PD-L1–Expressing Advanced NSCLC: Real-World Time on Treatment and Overall Survival
10:15 - 10:15 | Presenter: Vamsidhar Velcheti
- Abstract
Loading... -
+
P2.16-42 - The Use of a Smartphone Application Improves Postoperative Outcomes in Patients Undergoing Lung Cancer Resection (Now Available)
10:15 - 10:15 | Presenter: Carlos Alfredo Fraile Olivero
- Abstract
Loading... -
+
P2.16-43 - Immunotherapy in Elderlies. Real World Data (Now Available)
10:15 - 10:15 | Presenter: Luis Felipe Sánchez-Cousido
- Abstract
Loading... -
+
P2.16-44 - Real-World Treatment Patterns and Outcomes in ALK+ NSCLC Patients Receiving Immuno-Oncology Therapy in the United States
10:15 - 10:15 | Author(s): Xiaoyun Pan
- Abstract
Loading...
-
+
P2.17 - Treatment of Early Stage/Localized Disease
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment of Early Stage/Localized Disease
- Presentations: 14
- Now Available
- Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
-
+
P2.17-01 - Analysis of Clinical Features and Prognosis of Non-Small Cell Lung Cancer Exceeding 30 mm Depending on the Ground Glass Opacity (GGO) Ratio
10:15 - 10:15 | Presenter: Atsushi Kagimoto
- Abstract
Loading... -
+
P2.17-02 - Survival in Performance Status 3 Non-Small Cell Lung Cancer Patients Receiving Radical Radiotherapy
10:15 - 10:15 | Presenter: Roya Behrouzi
- Abstract
Loading... -
+
P2.17-03 - Surgical Outcomes of Repeated Anatomical Pulmonary Resection for the Ipsilateral Second Lung Cancers
10:15 - 10:15 | Presenter: Aritoshi Hattori
- Abstract
Loading... -
+
P2.17-04 - Role of Lymphadenectomy in Thoracoscopic Lobectomy for Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Samina Park
- Abstract
Loading... -
+
P2.17-05 - Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC
10:15 - 10:15 | Presenter: Naoko Katsurada
- Abstract
Loading... -
+
P2.17-06 - Analysis of Left Atrial Blood Flow Using 4D Flow MRI in the Patient Who Suffered from Cerebral Infarction After Left Upper Lobectomy (Now Available)
10:15 - 10:15 | Presenter: Mitsuo Matsumoto
- Abstract
Loading... -
+
P2.17-07 - Role of Adjuvant Chemotherapy After Sublobar Resection in Stage I NSCLC
10:15 - 10:15 | Presenter: Ranjan Pathak
- Abstract
Loading... -
+
P2.17-08 - Ethanol Release Heat-Generating Polymer for Focal Therapy of Small Lung Cancers Under Open MRI
10:15 - 10:15 | Presenter: Junichi Shimada
- Abstract
Loading... -
+
P2.17-09 - Preoperative Risk Factors of Potential Failure for Lobe-Specific Nodal Dissection in Clinical Early Stage (I-IIA) Non-Small Cell Lung Cancer
10:15 - 10:15 | Author(s): Yooyoung Chong
- Abstract
Loading... -
+
P2.17-10 - Effects of the Omega-6/Omega-3 Ratio on Postoperative Complications After Lung Resection: Preliminary Results
10:15 - 10:15 | Presenter: Carlos Deniz
- Abstract
Loading... -
+
P2.17-11 - Evaluating PD-L1 as a Prognostic Biomarker in Surgically Resectable Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Stephanie Tuminello
- Abstract
Loading... -
+
P2.17-12 - Robotic Assisted Segmentectomy - Intravenous vs Intrabronchial Fluorescence Thoracoscopy to Identify the Intersegmental Plane (Now Available)
10:15 - 10:15 | Presenter: Styliani Maria Kolokotroni
- Abstract
Loading... -
+
P2.17-13 - Thoracoscore Fails to Predict In-Hospital Mortality Following Elective Surgery in a Brazilian Lung Cancer Cohort (Now Available)
10:15 - 10:15 | Presenter: Eliza Dalsasso Ricardo
- Abstract
Loading... -
+
P2.17-14 - Impaired Immune Defense in Tumor Micro-Environment Is Associated with Risk of Recurrence in Early Stage Lung Adenocarcinoma
10:15 - 10:15 | Presenter: Yanyan Lou
- Abstract
Loading... -
+
P2.17-15 - Clinical Features and Prognosis of Lung Cancer with Cavity Lesion
10:15 - 10:15 | Presenter: Hiromichi Okuma
- Abstract
Loading... -
+
P2.17-16 - Genomic Heterogeneity and Evolutionary Trajectory in Multifocal Synchronous Lung Cancer
10:15 - 10:15 | Presenter: Si-Yang Liu
- Abstract
Loading... -
+
P2.17-17 - Clinical Effect of Adjuvant Chemotherapy on Stage IB NSCLC with High-Risk Factors
10:15 - 10:15 | Presenter: Juwhan Choi
- Abstract
Loading... -
+
P2.17-18 - Acute Respiratory Distress Syndrome After Curative Surgical Resection for Lung Cancer (Now Available)
10:15 - 10:15 | Author(s): Soohwan Choi
- Abstract
Loading... -
+
P2.17-19 - Quality of Life After Pulmonary Stereotactic Fractionated Radiotherapy: Longterm Results of the Phase II STRIPE Trial
10:15 - 10:15 | Author(s): Sonja Adebahr
- Abstract
Loading... -
+
P2.17-20 - A Radiomic Approach to Predict Nodal and Distant Relapse in Patients Treated with Stereotactic Body Radiation Therapy for Early Stage NSCLC (Now Available)
10:15 - 10:15 | Presenter: Davide Franceschini
- Abstract
Loading... -
+
P2.17-21 - A Post-Hoc Analysis of TROG 09.02 (CHISEL) Phase III Trial Investigating Pulmonary Function Changes After SABR and Conformal Radiation Therapy (Now Available)
10:15 - 10:15 | Presenter: Nicholas Wentworth Bucknell
- Abstract
Loading... -
+
P2.17-22 - Retrospective Analysis of Spread Through Air Spaces and Other Features in Patients with Stage IA Adenocarcinoma by the 8th TNM Classification
10:15 - 10:15 | Presenter: Keita Nakao
- Abstract
Loading... -
+
P2.17-23 - The Role Adjuvant Chemotherapy in Resected Stage 1 NSCLC with High Risk Factors: A Turkish Oncology Group Study (Now Available)
10:15 - 10:15 | Presenter: Yesim Eralp
- Abstract
Loading... -
+
P2.17-24 - Minimally Invasive Surgery for Lung Cancer Improves Short Term Outcomes in Patients with History of Head and Neck Carcinoma
10:15 - 10:15 | Presenter: David Boulate
- Abstract
Loading... -
+
P2.17-25 - Genomic Insight into Stage I Pulmonary Adenocarcinoma for Recurrence by Targeted Next-Generation Sequencing Analysis
10:15 - 10:15 | Presenter: In Ae Kim
- Abstract
Loading... -
+
P2.17-26 - Indocyanine Green Virtual Assisted Lung Mapping (ICG-VAL-MAP): Anyone Can Perform a Successful Preoperative Marking for a Small Lung Nodule (Now Available)
10:15 - 10:15 | Presenter: Toyofumi Fengshi Chen-Yoshikawa
- Abstract
Loading... -
+
P2.17-27 - Evaluation of Mediastinal Lymphadenectomy Quality in Patients Operated for NSCLC from the Paulista Lung Cancer Registry (PLCR)
10:15 - 10:15 | Presenter: Leticia Leticia Lauricella
- Abstract
Loading... -
+
P2.17-28 - Examination of the Indication and Validity of Segmental Resection as Intentional and Palliative Limited Resection for Lung Cancer (Now Available)
10:15 - 10:15 | Presenter: Katsuo Kojima
- Abstract
Loading... -
+
P2.17-29 - Impact of Second Predominant Pattern on Recurrence in Early Stage Resected Lung Adenocarcinoma: A Multicentric Study (Now Available)
10:15 - 10:15 | Presenter: Pietro Bertoglio
- Abstract
Loading... -
+
P2.17-30 - Superior Vena Cava Resection and Prosthetic Replacement for NSCLC: Is It Worthwhile? (Now Available)
10:15 - 10:15 | Presenter: Josephine Chenesseau
- Abstract
Loading... -
+
P2.17-31 - Central Lung Tumors Treated with Stereotactic Radiotherapy. Toxicity and Early Results in a Single Institution
10:15 - 10:15 | Presenter: Miriam Nuñez Fernandez
- Abstract
Loading... -
+
P2.17-32 - Using Next-Generation Sequencing to Identify Genetic Predictors of Local Failure After Lung Stereotactic Body Radiation Therapy (Now Available)
10:15 - 10:15 | Presenter: Victor Chan Ng
- Abstract
Loading... -
+
P2.17-33 - Deterioration in Health-Related Quality of Life Is Associated with Lower Lung Resection Rates in Older Adults
10:15 - 10:15 | Author(s): Andrew M Blakely
- Abstract
Loading... -
+
P2.17-34 - Integrated Clinico-Radiomic Nomogram for Predicting Disease-Free Survival (DFS) in Stage I and II Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Kaustav Bera
- Abstract
Loading... -
+
P2.17-35 - Integrating CT Radiomic & Quantitative Histomorphometric Whole Slide Image Features Predicts Disease Free Survival in ES-NSCLC
10:15 - 10:15 | Presenter: Pranjal Vaidya
- Abstract
Loading... -
+
P2.17-36 - Molecular Markers, Therapeutic and Prognostic Analysis of Lung Sarcomatoid Carcinomas
10:15 - 10:15 | Presenter: Wenhua Liang
- Abstract
Loading... -
+
P2.17-37 - Prognostic Implication of Surgical Treatment for the Dominant Lung Adenocarcinoma Associated with Part-Solid Nodules
10:15 - 10:15 | Presenter: Yoohwa Hwang
- Abstract
Loading... -
+
P2.17-38 - Predictive Factors for Lymph Node Metastasis in Patients with Clinical Stage I Part-Solid Lung Adenocarcinoma
10:15 - 10:15 | Author(s): Jae Hyun Jeon
- Abstract
Loading... -
+
P2.17-39 - Relationship Between EGFR Mutation and Pathological Differentiation in Patients with Clinical Stage IA Lung Adenocarcinoma
10:15 - 10:15 | Presenter: Junichiro Osawa
- Abstract
Loading... -
+
P2.17-40 - Analysis of 7 Years Experiences of Uniportal Video-Assisted Thoracic Surgery for Stage I and II Lung Cancer (Now Available)
10:15 - 10:15 | Presenter: Do Kyun Kang
- Abstract
Loading... -
+
P2.17-41 - Treatment Outcomes of Pulmonary Resection in NSCLC Patients with Autoimmune Diseases
10:15 - 10:15 | Presenter: Shota Fukuda
- Abstract
Loading... -
+
P2.17-42 - Surgical Choice for Clinical Stage IA Non-Small Cell Lung Cancer: Novel Rationale from Intrapulmonary Lymph Node Metastasis Pattern
10:15 - 10:15 | Presenter: Han-Yu Deng
- Abstract
Loading... -
+
P2.17-43 - Complete Uniportal Thoracoscopic Anatomic Lung Resection with Systematic Mediastinal Lymphadenectomy for NSCLC (Now Available)
10:15 - 10:15 | Presenter: Youjun Deng
- Abstract
Loading...
-
+
P2.18 - Treatment of Locoregional Disease - NSCLC
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment of Locoregional Disease - NSCLC
- Presentations: 11
- Now Available
- Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
-
+
P2.18-01 - A Multicenter, Double-Blind, Randomized, Controlled Study of Bintrafusp Alfa (M7824) in Unresectable Stage III NSCLC (Now Available)
10:15 - 10:15 | Presenter: Everett E. Vokes
- Abstract
Loading... -
+
P2.18-02 - Pneumonectomy and Lung Cancer: A Treacherous Combination
10:15 - 10:15 | Presenter: Lawek Berzenji
- Abstract
Loading... -
+
P2.18-03 - Salvage Surgery After Curative-Intent Chemo and/or Radiation for Locally Advanced Lung Cancer (Now Available)
10:15 - 10:15 | Presenter: Motohiro Yamashita
- Abstract
Loading... -
+
P2.18-04 - Improved Outcome in Female Stage III NSCLC Diagnoses Is Driven by Non-Curative Intent Treatment, and Adenocarcinoma Histology
10:15 - 10:15 | Author(s): Noor Asaad Alsaadoun
- Abstract
Loading... -
+
P2.18-05 - Patients with ypN2 NSCLC After Neoadjuvant Chemotherapy Followed by Surgery Can Benefit from PORT – A Retrospective Study of SEER Database (Now Available)
10:15 - 10:15 | Presenter: Yongxing Bao
- Abstract
Loading... -
+
P2.18-06 - Trends and Outcomes of Minimally Invasive Approaches for Lung Cancer Resection After Induction Therapy in the United States (Now Available)
10:15 - 10:15 | Author(s): Mohamed K Kamel
- Abstract
Loading... -
+
P2.18-07 - Prognostic Factors Affecting Brain Metastasis-Free Survival in Non-Small Cell Lung Cancer Patients (Now Available)
10:15 - 10:15 | Author(s): Fatma Sert
- Abstract
Loading... -
+
P2.18-08 - The Necessity and Technique of the Upper Zone Lymph Node Dissection for Non-Small-Cell Carcinoma of the Left Upper Lobe
10:15 - 10:15 | Presenter: Toshiya Yokota
- Abstract
Loading... -
+
P2.18-09 - Age Does Not Affect the Benefit of Modern Chemoradiation for LA-NSCLC Patients (Now Available)
10:15 - 10:15 | Presenter: Sara Ramella
- Abstract
Loading... -
+
P2.18-10 - Importance of the Multidisciplinary Tumor Board in the Treatment Strategy of Stage III Non-Small Cell Lung Cancer (NSCLC) (Now Available)
10:15 - 10:15 | Presenter: Justin Benet
- Abstract
Loading... -
+
P2.18-11 - Real-World Experience of Consolidation Durvalumab for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
10:15 - 10:15 | Presenter: Alexander Michael Barbaro
- Abstract
Loading... -
+
P2.18-12 - Prognostic Nutrition Index Affects Prognosis of Trimodality Therapy for Locally Advanced Lung Cancer with High T Factor (Now Available)
10:15 - 10:15 | Presenter: Junichi Soh
- Abstract
Loading... -
+
P2.18-13 - Endobronchial Brachytherapy: A Single Institutional Experience
10:15 - 10:15 | Presenter: Pere Trias Sabrià
- Abstract
Loading... -
+
P2.18-14 - The Role of Surgery in High Grade Neuroendocrine Tumors of the Lung (Now Available)
10:15 - 10:15 | Presenter: Mehmet ALİ Bedİrhan
- Abstract
Loading... -
+
P2.18-15 - Surgical Outcomes of Pneumonectomy After Induction Therapy for Non-Small-Cell Lung Cancer (Now Available)
10:15 - 10:15 | Presenter: Norihito Okumura
- Abstract
Loading... -
+
P2.18-16 - VATS Lobectomy and Chest Wall Resection for NSCLC
10:15 - 10:15 | Presenter: Hüseyin Melek
- Abstract
Loading... -
+
P2.18-17 - Outcome of Surgical Treatment for Clinical N1 Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Daiji Nemoto
- Abstract
Loading... -
+
P2.18-18 - Impact of Combined Evaluation Using Tumor Volume and Metastatic Nodal Extent in Stage III NSCLC Treated with CRT
10:15 - 10:15 | Presenter: Yutaro Tamiya
- Abstract
Loading... -
+
P2.18-19 - Radiological and Pathological Response to the Induction of Surgery in the NSCLC Stage III (Now Available)
10:15 - 10:15 | Presenter: Francesc Casas
- Abstract
Loading...
-
+
PR03 - Press Conference
- Type: Press Conference
- Track:
- Presentations: 7
- Now Available
- Coordinates: 9/09/2019, 10:15 - 11:00, CC7.1 A&B
-
+
PR03.01 - Summary of Day's Plenary
10:15 - 10:20
- Abstract
No abstract available for this presentation
-
+
PR03.02 - Lung Cancer Screenee Selection by USPSTF Versus PLCOm2012 Criteria – Interim ILST Findings (Now Available)
10:20 - 10:26
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PR03.03 - Early Detection of Cancer of the Lung Scotland (ECLS): Trial Results (Now Available)
10:26 - 10:32
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PR03.04 - Blood MicroRNA and LDCT Reduce Unnecessary LDCT Repeats in Lung Cancer Screening: Results of Prospective BioMILD Trial (Now Available)
10:32 - 10:38
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PR03.05 - In Hospital Clinical Efficacy, Safety and Oncologic Outcomes from VIOLET: A UK Multi-Centre RCT of VATS Versus Open Lobectomy for Lung Cancer (Now Available)
10:38 - 10:44
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PR03.06 - Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers (Now Available)
10:44 - 10:50
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PR03.07 - National Lung Matrix Trial (NLMT): First Results from an Umbrella Phase II Trial in Advanced Non-Small Cell Lung Cancer (NSCLC) (Now Available)
10:50 - 10:55
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
PR03.08 - Overall Survival with Durvalumab Plus Etoposide-Platinum in First-Line Extensive-Stage SCLC: Results from the CASPIAN Study (Now Available)
10:55 - 11:00
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
CS01 - Controversies in NSCLC OMD
- Type: Controversy Session
- Track: Oligometastatic NSCLC
- Presentations: 5
- Now Available
- Moderators:Tomoyuki Hishida
- Coordinates: 9/09/2019, 11:00 - 12:30, Colorado Springs (1994)
-
+
CS01.01 - "Hunting a Ghost for 25 Years – Will We Ever Catch OMD?" - No (Now Available)
03:30 - 03:50 | Presenter: Tom Treasure
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
CS01.02 - "Hunting a Ghost for 25 Years – Will We Ever Catch OMD?" - Yes (Now Available)
11:20 - 11:40 | Presenter: José Belderbos
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
CS01.03 - Technical Reasons of Local Treatment Define the Limits of NSCLC OMD in Terms of Number of Metastases, Not a Fixed Number (Now Available)
11:40 - 12:00 | Presenter: Marta Scorsetti
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
CS01.04 - NSCLC OMD is Defined by a Fixed Maximum Number of Metastases, Not Technical Reasons of Local Treatment (Now Available)
12:00 - 12:20 | Presenter: GAVIN Michael WRIGHT
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
CS01.05 - Q&A (Now Available)
12:20 - 12:30
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
first
prev
